Arkolith/Insider Trading/HQL/Form 4

Saba Capital Management, L.P.

10% Ownerabrdn Life Sciences Investors (HQL) · full profile →Form 4 · filed May 2, 2024
Net Buying
Open-Market Buys
$357K
Open-Market Sells
$0
Net Open-Market Flow
$357K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 2, 2024Buy(P)26K$13.46$354K3.1M
May 1, 2024Buy(P)252$13.02$3K3.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001510281-24-000270) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML